UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(D) of The Securities Exchange Act of 1934
Date of report (Date of earliest event reported): February 7, 2008
Patriot Scientific Corporation
(Exact name of registrant as specified in its charter)
Delaware | 0-22182 | 84-1070278 |
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
Carlsbad Corporate Plaza
6183 Paseo Del Norte, Suite 180
Carlsbad, CA 92011
(Address of principal executive offices, zip code)
(760) 547-2700
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (127 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On February 7, 2008, Mr. David Pohl, the chairman of the board of directors (the “Board”) of Patriot Scientific Corporation (the “Company”), notified the Board by letter that he was resigning his position as chairman and as a member of the Board in order to spend more time on personal and family matters. A copy of the letter from Mr. Pohl is attached hereto as Exhibit 99.1.
The Company expressly disclaims any obligation to update this letter and cautions that it is only accurate on the date it was presented. The inclusion of any data or statements in this letter does not signify that the information is considered material.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
99.1 Letter dated February 7, 2008
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Patriot Scientific Corporation (Registrant) | |
| | | |
Date: February 8, 2008 | By: | /s/ Clifford Flowers | |
| | Clifford Flowers | |
| | Chief Financial Officer | |
| | | |